silybin has been researched along with Body Weight in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Cossiga, V; Dallio, M; Di Sarno, R; Federico, A; Gravina, AG; Lama, S; Loguercio, C; Masarone, M; Morisco, F; Persico, M; Stiuso, P; Tuccillo, C | 1 |
| Ababneh, Q; Alsaggar, M; Alzoubi, KH; Bdour, S; El-Elimat, T; Qinna, N | 1 |
| Çelik, DA; Özçelik, N; Sevimli, M; Sevimli, TS; Toğay, VA | 1 |
| Agarwal, R; Chittezhath, M; Deep, G; Raina, K; Rajamanickam, S; Singh, RP | 1 |
| Felix, AJ; Nalini, N; Sangeetha, N | 1 |
| Dunnick, JK; Kissling, GE; Nyska, A; Peckham, J; Sanders, JM; Singh, B | 1 |
| Bosco, P; Di Giacomo, C; Galvano, F; La Delia, F; Li Volti, G; Malaguarnera, M; Marrazzo, G; Nicolosi, A; Scapagnini, G | 1 |
| La Grange, L; Montoya, R; Moreland, N | 1 |
| Brown, K; Gescher, AJ; Greaves, P; Marsden, DA; Patel, K; Steward, WP; Verschoyle, RD | 1 |
1 trial(s) available for silybin and Body Weight
| Article | Year |
|---|---|
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients.
Topics: Adult; Aged; Biomarkers; Body Weight; Cytokines; Drug Therapy, Combination; Endothelial Cells; Female; Humans; Insulin Resistance; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Silybin; Vitamin D; Vitamin E | 2019 |
8 other study(ies) available for silybin and Body Weight
| Article | Year |
|---|---|
Silibinin attenuates adipose tissue inflammation and reverses obesity and its complications in diet-induced obesity model in mice.
Topics: Adipocytes; Adipose Tissue; Animals; Anti-Inflammatory Agents; Anti-Obesity Agents; Body Weight; Diet, High-Fat; Disease Models, Animal; Gene Expression; Glucose; Hypertrophy; Liver; Male; Mice, Inbred C57BL; Obesity; Silybin | 2020 |
DNA damage in rats with streptozotocin-induced diabetes; protective effect of silibinin.
Topics: Animals; Body Weight; Case-Control Studies; Comet Assay; Diabetes Mellitus, Experimental; DNA Damage; Male; Rats; Silybin | 2018 |
Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
Topics: Adenocarcinoma; Animals; Antioxidants; Apoptosis; Biomarkers, Tumor; Blotting, Western; Body Weight; Cell Cycle Proteins; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Female; Humans; Immunoenzyme Techniques; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Mice, Transgenic; Neoplasm Staging; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Silybin; Silybum marianum; Silymarin; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2008 |
Silibinin modulates biotransforming microbial enzymes and prevents 1,2-dimethylhydrazine-induced preneoplastic changes in experimental colon cancer.
Topics: 1,2-Dimethylhydrazine; Animals; Anticarcinogenic Agents; Bacteria; Body Weight; Colon; Colonic Neoplasms; Disease Models, Animal; Male; Precancerous Conditions; Rats; Rats, Wistar; Silybin; Silymarin | 2009 |
Investigating the potential for toxicity from long-term use of the herbal products, goldenseal and milk thistle.
Topics: Animals; Berberine; Body Weight; Carcinogens; Female; Flavonolignans; Hydrastis; Liver Neoplasms; Male; Mice; Mice, Inbred Strains; Plant Preparations; Plant Roots; Rats; Rats, Inbred F344; Silybin; Silybum marianum; Silymarin; Topoisomerase Inhibitors; Toxicity Tests, Chronic | 2011 |
Neuroprotective effect of silibinin in diabetic mice.
Topics: Animals; Antioxidants; Body Weight; Brain; Brain Chemistry; Diabetes Mellitus, Type 2; DNA Damage; Drug Evaluation, Preclinical; Heme Oxygenase-1; Lipid Peroxidation; Membrane Proteins; Metalloporphyrins; Mice; Mice, Knockout; Mice, Mutant Strains; Nerve Tissue Proteins; Neuroprotective Agents; Oxidative Stress; Receptors, Leptin; Silybin; Silymarin | 2011 |
Impact of in utero exposure to EtOH on corpus callosum development and paw preference in rats: protective effects of silymarin.
Topics: Agenesis of Corpus Callosum; Analysis of Variance; Animals; Body Weight; Brain; Corpus Callosum; Ethanol; Female; Fetal Alcohol Spectrum Disorders; Functional Laterality; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Protective Agents; Rats; Rats, Inbred F344; Silybin; Silymarin | 2002 |
Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels.
Topics: Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Chromatography, High Pressure Liquid; Drug Evaluation; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Prostatic Neoplasms; Silybin; Silymarin | 2008 |